中国中医药信息杂志Issue(5)：132-136,5.DOI:10.3969/j.issn.1005-5304.2015.05.041
维药新药治疗湿疹临床研究指导原则（草案）
Clinical Research Guidelines for the Treatment of Eczema with New Uyghur Medicine ;(Draft)
摘要
Abstract
Retrospective multi-center study on medical records of Uyghur medicine diagnosis and treatment program of eczema was done. Demography, diagnostics, therapeutics, efficacy evaluation and nursing data and other information were collated and analyzed. With analysis and summary of the primary and the secondary symptoms, eczema was divided into four types:blood corruption type (Ofunetlengen Kan Tiplik), blue colored yellow bile type (Zenggereng Sapra Tiplik), abnormal black bile type (Hayri Tabii Savda Hilitlik), and salty phlegm type (Shor Belgem Hilitlik). Uyghur Medicine syndrome differentiation and efficacy evaluation criteria were established. Skin itching, lesion shape, and lesion area integral of patients were scored before and after the treatment, respectively. According to the improvement in symptoms of Uyghur medicine syndrome and life quality of patients, and the internal environment change, evaluation criteria for the efficacy of disease symptom combination were established. On this basis, in accordance with the technical requirements of the national new medicine assessment technology, the study developed clinical research guidelines for the treatment of eczema with new Uyghur medicine.关键词
湿疹/维医药/诊断技术和方法/临床研究指导原则Key words
eczema/Uyghur medicine/diagnostic technique and method/clinical research guideline分类
医药卫生引用本文复制引用
斯拉甫·艾白,阿布都吉力力·阿布都艾尼,买尼沙·买买提,吐尔逊·吾甫尔,王平山,李攻戍,刘炳林,裴小静,唐健元,李治建..维药新药治疗湿疹临床研究指导原则（草案）[J].中国中医药信息杂志,2015,(5):132-136,5.基金项目
新疆维吾尔自治区科技计划项目(201133126) （201133126）
